The Controversial Battle of E-Cigarette Regulations.

Jul.30.2022
The Controversial Battle of E-Cigarette Regulations.
US crackdown on individual e-cigarette shops poses challenges for entrepreneurship, public health & personal freedom. State and local gov'ts impose stricter regulations.

Various state and local governments in the United States are cracking down on individual e-cigarette retailers, which is a bad deal for entrepreneurship, public health, and individual freedom.


Juul, a leading company in the production of nicotine vape, has recently made headlines. The FDA ordered Juul to be taken off the market and banned the legal sale of their products. However, a court in the Washington D.C area has temporarily suspended the order, allowing Juul to continue selling their products. The legal future of Juul, however, remains uncertain.


Although the federal government is taking strong measures against Juul, state and local governments are engaged in another battle over e-cigarettes. Various states and locales in the US have begun to restrict the locations where "vape shops" can operate, with North Carolina still relatively open to it, only requiring a permit to sell e-cigarette products. However, stricter regulations are being implemented across the country.


Regulations in other states and localities often include bans on opening e-cigarette shops near schools and daycares, with such prohibitions potentially extending to churches, parks, and sports fields. The established goal of these policies is to prevent the sale of e-cigarette products to minors, but interestingly, these laws do not apply to convenience stores and gas stations, which typically sell e-cigarette products. Therefore, while it may be prohibited to open an e-cigarette shop near a church, the gas station across the street can freely sell e-cigarette products.


Utah stands out as a state with particularly strict regulations. To open an e-cigarette shop in Utah, one must first obtain an e-cigarette permit from the state government, as well as a tobacco retail permit from the local health department. Additionally, opening an e-cigarette shop within 1,000 feet of a "community center," including schools, playgrounds, daycare centers, and churches, is prohibited. Density restrictions also apply to e-cigarette retailers, with tobacco specialty shops required to be at least 600 feet apart. Finally, Utah goes further by prohibiting e-cigarette shops within 600 feet of agricultural or residential properties. Like other states, these regulations do not apply to other retailers who may sell e-cigarettes, creating an uneven competitive environment.


These bans often feel like the right course of action. We should protect the health and safety of children and prevent them from being exposed to harmful substances. However, this sentiment cannot tell us whether these bans will have the intended effect. In particular, certain policies create difficulties for electronic cigarette shop owners and adult smokers seeking harm reduction products, and decision-makers should consider the facts.


Additionally, these bans typically do not include other hybrid retailers who sell e-cigarette products, such as gas stations, grocery stores, and convenience stores. Targeting e-cigarette store owners without limiting the sale of these products in other stores is an abuse of state power. These e-cigarette stores are often owned and operated by individual shop owners who already face licensing requirements, cumbersome tax systems and other requirements, and now they must face an even more imbalanced competitive environment, competing with big companies like grocery store and gas station chains to sell e-cigarettes.


The government should not discriminate against specific industries, and those seeking alternatives to traditional tobacco products should still have the option to choose electronic cigarettes. Policy should be based on rigorous evidence and balanced to protect both minors and users of e-cigarettes. Simply distinguishing sales often fails to achieve these goals while harming small business owners and favoring the interests of large retail chains.


I'm sorry, as an AI language model, I am already programmed to use standard journalistic English. Please provide me with the text that needs to be translated.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

Product | OXVA Introduces XLIM PRO 4 With Liquid-Level Anti-Burn Technology and Dedicated Pods
Product | OXVA Introduces XLIM PRO 4 With Liquid-Level Anti-Burn Technology and Dedicated Pods
Vaping brand OXVA introduced the XLIM PRO 4 refillable pod system in October 2026, featuring Anti-Burn Tech (ABT) based on smart e-liquid-level detection. The system can issue refill alerts and stop power output when e-liquid levels become too low. ABT requires the XLIM PRO 4 device and a dedicated XLIM ABT cartridge. Standard XLIM pods remain compatible but do not support ABT protection. OXVA previously introduced temperature-based anti-burn technology in the XLIM Pro 2 DNA, developed with Evolv. The new device features a 1,800mAh battery, 5–30W output and a 0.98-inch HD color screen. OXVA's official store lists the device at $37.90 and dedicated ABT replacement cartridges at $12.99. Independent testing confirmed the low-liquid protection response but recorded varying cartridge lifespans.
product
Oct.30
US ITC Judge Finds Glas Infringed Two JUUL Vape Patents, Recommends Restrictions on Related Imports——Glas Received FDA Marketing Authorization for Four Vape Pods in May 2026; Proposed Restrictions Remain Under Commission Review
US ITC Judge Finds Glas Infringed Two JUUL Vape Patents, Recommends Restrictions on Related Imports——Glas Received FDA Marketing Authorization for Four Vape Pods in May 2026; Proposed Restrictions Remain Under Commission Review
A U.S. International Trade Commission (USITC) administrative law judge issued an initial determination on October 20, 2026, finding that certain Glas vaping devices, cartridges and components infringed 12 claims across two patents asserted by JUUL, constituting a violation of Section 337 of the Tariff Act of 1930. The judge recommended a limited exclusion order and a cease and desist order against the Glas respondents. Five months earlier, the FDA authorized four Glas e-cigarette pods, including mango, blueberry and two menthol variants. The patent investigation concerns device and cartridge structures and is separate from FDA premarket review. The proposed import restrictions have not become final, and their product-level scope remains unresolved.
company
Nov.05
Special Report | Can Nicotine Be Replaced? 6-MN Is Already on the Market While Key Human Evidence Is Still Missing
Special Report | Can Nicotine Be Replaced? 6-MN Is Already on the Market While Key Human Evidence Is Still Missing
Nicotine analogues such as 6-methylnicotine are already appearing in e-cigarettes and oral pouches, even as key human evidence remains limited. A new Nixodine-S study adds nonclinical data showing differences from nicotine in cytotoxicity and receptor activity, while independent studies point to a more complex toxicological picture. With supply-chain activity growing and FDA seeking clearer authority over nicotine analogues, the industry now faces a larger question: what evidence is needed before these substances can credibly replace nicotine?
SCIENCE
Sep.23
Special Report | From New York to Washington: How FDA’s Tobacco Center Is Reworking Product Review
Special Report | From New York to Washington: How FDA’s Tobacco Center Is Reworking Product Review
FDA’s Center for Tobacco Products is reshaping how it approaches tobacco product review. Based on 2Firsts’ on-site reporting in New York and Washington, this report traces CTP’s emerging direction: stronger links between PMTA and tobacco harm reduction, more category-specific review, greater emphasis on decision-relevant science, more predictable timelines and expanded use of sPMTA for product modifications. CTP also acknowledged major constraints, including just nine PMTA review teams, persistent backlogs and limits on hiring capacity.
Regulations
Oct.08
Why Does JPMorgan Favor BAT Over Philip Morris Despite Forecasting Slower Growth of 3.9% Versus 6.2%?
Why Does JPMorgan Favor BAT Over Philip Morris Despite Forecasting Slower Growth of 3.9% Versus 6.2%?
JPMorgan resumed equity research coverage of British American Tobacco (BAT), Philip Morris International (PMI) and Imperial Brands in November 2026, assigning BAT an Overweight rating and the other two companies Neutral ratings. The bank forecasts like-for-like sales growth of 3.9% for BAT and 6.2% for PMI in 2027, but estimates the two companies will trade at approximately 11 times and 21 times 2027 earnings, respectively. JPMorgan cited BAT's improving position in US nicotine pouches and vaping products as a driver of its investment outlook. BAT reported a 220% constant-currency increase in US modern oral nicotine revenue in the first half of 2026, while PMI's ZYN US shipments returned to growth in the third quarter. Imperial expects NGPs to represent 4% to 5% of sales and has expanded its oral portfolio through acquisitions.
Capital Markets
Nov.12
On-Site Report | CTP Details PMTA Backlog, 180-Day Review Goal and sPMTA Process
On-Site Report | CTP Details PMTA Backlog, 180-Day Review Goal and sPMTA Process
FDA’s Center for Tobacco Products detailed new PMTA review data and process changes at the 2026 FDLI conference. Pending PMTAs fell from about 450,000 at the start of 2025 to 135,000 by September 2026. CTP also discussed its 180-day review goal, current sPMTA pilot, alternate-supplier planning, more than 50,300 pending SE reports, and lessons from the nicotine pouch pilot already being applied to ENDS review.
Regulations
Oct.07